StreetInsider.com News Articles

Capella University names oncologist Dr. Saro Sarkisian to board

Thu, 20 Aug 2026 07:01:11 -0400

Capella University has appointed Saro Sarkisian, MD, MHA, to its Board of Trustees, according to a statement from the Minneapolis-based online university.

Dr. Sarkisian is a board-certified medical oncologist and hematologist who currently serves as Clinical Director of Cellular Therapeutics at Frederick Health and practices at the James M. Stockman Cancer Institute in Frederick, Maryland. He has served as a lead oncologist in clinical settings and as a principal investigator on national and international clinical trials.

Dr. Sarkisian has advised on the development of immuno-oncology therapeutics, including antibody-drug conjugates and monoclonal antibodies, and has contributed to the expansion of oncology access in

Capella University names oncologist Dr. Saro Sarkisian to board

Thu, 20 Aug 2026 07:01:11 -0400

Capella University has appointed Saro Sarkisian, MD, MHA, to its Board of Trustees, according to a statement from the Minneapolis-based online university.

Dr. Sarkisian has advised on the development of immuno-oncology therapeutics, including antibody-drug conjugates and monoclonal antibodies, and has contributed to the expansion of oncology access in

Capella University names oncologist Dr. Saro Sarkisian to board

Thu, 20 Aug 2026 07:01:11 -0400

Capella University has appointed Saro Sarkisian, MD, MHA, to its Board of Trustees, according to a statement from the Minneapolis-based online university.

Dr. Sarkisian has advised on the development of immuno-oncology therapeutics, including antibody-drug conjugates and monoclonal antibodies, and has contributed to the expansion of oncology access in

Capella University names oncologist Dr. Saro Sarkisian to board

Thu, 20 Aug 2026 07:01:11 -0400

Capella University has appointed Saro Sarkisian, MD, MHA, to its Board of Trustees, according to a statement from the Minneapolis-based online university.

Dr. Sarkisian has advised on the development of immuno-oncology therapeutics, including antibody-drug conjugates and monoclonal antibodies, and has contributed to the expansion of oncology access in

Capella University names oncologist Dr. Saro Sarkisian to board

Thu, 20 Aug 2026 07:01:11 -0400

Capella University has appointed Saro Sarkisian, MD, MHA, to its Board of Trustees, according to a statement from the Minneapolis-based online university.

Dr. Sarkisian has advised on the development of immuno-oncology therapeutics, including antibody-drug conjugates and monoclonal antibodies, and has contributed to the expansion of oncology access in

Capella University names oncologist Dr. Saro Sarkisian to board

Thu, 20 Aug 2026 07:01:11 -0400

Capella University has appointed Saro Sarkisian, MD, MHA, to its Board of Trustees, according to a statement from the Minneapolis-based online university.

Dr. Sarkisian has advised on the development of immuno-oncology therapeutics, including antibody-drug conjugates and monoclonal antibodies, and has contributed to the expansion of oncology access in

Capella University names oncologist Dr. Saro Sarkisian to board

Thu, 20 Aug 2026 07:01:11 -0400

Capella University has appointed Saro Sarkisian, MD, MHA, to its Board of Trustees, according to a statement from the Minneapolis-based online university.

Dr. Sarkisian has advised on the development of immuno-oncology therapeutics, including antibody-drug conjugates and monoclonal antibodies, and has contributed to the expansion of oncology access in

Capella University names oncologist Dr. Saro Sarkisian to board

Thu, 20 Aug 2026 07:01:11 -0400

Capella University has appointed Saro Sarkisian, MD, MHA, to its Board of Trustees, according to a statement from the Minneapolis-based online university.

Dr. Sarkisian has advised on the development of immuno-oncology therapeutics, including antibody-drug conjugates and monoclonal antibodies, and has contributed to the expansion of oncology access in

Capella University names oncologist Dr. Saro Sarkisian to board

Thu, 20 Aug 2026 07:01:11 -0400

Capella University has appointed Saro Sarkisian, MD, MHA, to its Board of Trustees, according to a statement from the Minneapolis-based online university.

Dr. Sarkisian has advised on the development of immuno-oncology therapeutics, including antibody-drug conjugates and monoclonal antibodies, and has contributed to the expansion of oncology access in

Capella University names oncologist Dr. Saro Sarkisian to board

Thu, 20 Aug 2026 07:01:11 -0400

Capella University has appointed Saro Sarkisian, MD, MHA, to its Board of Trustees, according to a statement from the Minneapolis-based online university.

Dr. Sarkisian has advised on the development of immuno-oncology therapeutics, including antibody-drug conjugates and monoclonal antibodies, and has contributed to the expansion of oncology access in

Capella University names oncologist Dr. Saro Sarkisian to board

Thu, 20 Aug 2026 07:01:11 -0400

Capella University has appointed Saro Sarkisian, MD, MHA, to its Board of Trustees, according to a statement from the Minneapolis-based online university.

Dr. Sarkisian has advised on the development of immuno-oncology therapeutics, including antibody-drug conjugates and monoclonal antibodies, and has contributed to the expansion of oncology access in

Capella University names oncologist Dr. Saro Sarkisian to board

Thu, 20 Aug 2026 07:01:11 -0400

Capella University has appointed Saro Sarkisian, MD, MHA, to its Board of Trustees, according to a statement from the Minneapolis-based online university.

Dr. Sarkisian has advised on the development of immuno-oncology therapeutics, including antibody-drug conjugates and monoclonal antibodies, and has contributed to the expansion of oncology access in

Capella University Announces Appointment of Oncology Leader Dr. Saro Sarkisian to Board of Trustees